Defense Technologies International (DTII) 10-Q 23 Dec 24 2025 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Oct. 31, 2024	Dec. 23, 2024
Cover [Abstract]
Entity Registrant Name	DEFENSE TECHNOLOGIES INTERNATIONAL CORP.
Entity Central Index Key	0001533357
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--04-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Oct. 31, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Entity Common Stock Shares Outstanding		30,947,919
Entity File Number	000-54851
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	99-0363802
Entity Address Address Line 1	6700 N. Linder Road
Entity Address Address Line 2	Ste. 156-361
Entity Address City Or Town	Meridian
Entity Address State Or Province	ID
Entity Address Postal Zip Code	83646
City Area Code	800
Local Phone Number	520-9485
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Current assets:
Cash	$ 228	$ 171
Inventory	7,599	7,599
Total current assets	7,827	7,770
Total assets	7,827	7,770
Current liabilities:
Accounts payable and accrued expense	57,349	386,003
Accrued licenses agreement payable	0	87,500
Accrued interest and fees payable	187,963	178,188
Convertible notes payable, net of discount	279,085	279,085
Derivative liabilities	29,754	37,211
Payables - related parties	526,958	1,191,708
Customer deposits	40,375	40,375
Notes payable	70,042	20,042
Note payable- related party	150,680	150,020
Total current liabilities	1,342,206	2,370,132
Total liabilities	1,342,206	2,370,132
Commitments and Contingencies	0	0
Stockholders' deficit:
Common stock, $0.0001 par value; 600,000,000 shares authorized, 30,947,919 and 9,729,878 shares issued and outstanding, respectively	3,096	974
Additional paid-in capital	16,181,447	15,067,580
Accumulated deficit	(17,193,733)	(17,116,309)
Total	(1,008,831)	(2,047,316)
Non-controlling interest	(325,548)	(315,046)
Total stockholders' deficit	(1,334,379)	(2,362,362)
Total liabilities and stockholders' deficit	7,827	7,770
Series A Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	253	253
Series B Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	106	186
Series D Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	$ 0	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2024	Apr. 30, 2024
Preferred Stock, Par or Stated Value Per Share	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000
Preferred Stock, Shares Issued	3,598,969
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	600,000,000	600,000,000
Common Stock, Shares, Issued	30,947,919	9,729,878
Common Stock, Shares, Outstanding	30,947,919	9,729,878
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	2,535,135	2,535,135
Preferred Stock, Shares Outstanding	2,535,135	2,535,135
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized	5,000,000
Preferred Stock, Shares Issued	1,063,255	1,860,636
Preferred Stock, Shares Outstanding	1,063,255	1,860,636
Series D Preferred Stock [Member]
Preferred Stock, Shares Authorized	1,500,000
Preferred Stock, Shares Issued	579	600
Preferred Stock, Shares Outstanding	579	600

Condensed Consolidated Statemen

Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Condensed Consolidated Statement of Operations (Unaudited)
Revenue	$ 0	$ 49,012	$ 0	$ 49,012
Cost of goods sold	0	(24,395)	0	(24,395)
Gross margin	0	24,617	0	24,617
Expenses:
Consulting	219,292	112,637	336,792	232,637
Development		0	0	332
General and administrative	146,773	55,573	192,790	75,989
Total expenses	366,065	168,210	529,582	308,948
Loss from operations	(366,065)	(143,593)	(529,582)	(284,331)
Other income (expense):
Gain in debt settlement	723,065	0	723,065	0
Gain (loss )on accounts payable	45,000	0	(250,000)	0
Interest and other income (expense)	(7,096)	(7,189)	(14,154)	(14,559)
Loan origination fee	0	0	(5,000)	0
Loss on notes	0	0	(5,000)	0
Gain (loss) on derivative liability	(709)	(28,980)	7,457	(16,756)
Total other income (expense)	760,260	(36,169)	456,368	(31,315)
Income (loss) before income taxes	394,195	(179,762)	(73,214)	(315,646)
Provision for income taxes		0	0	0
Net income (loss) before non-controlling interest	394,195	(179,762)	(73,214)	(315,646)
Non- controlling interest in net loss of the consolidated subsidiary	4,332	645	10,502	8,410
Net income (loss) attributed to the Company	$ 398,527	$ (179,117)	$ (62,712)	$ (307,236)
Net income (loss) per common share: Basic	$ 0.01	$ (0.06)	$ 0	$ (0.11)
Net income (loss) per common share; Diluted	$ 0.01	$ (0.06)	$ 0	$ (0.11)
Weighted average common shares outstanding:
Basic	30,947,919	3,214,074	29,243,883	2,709,309
Weighted average common shares outstanding: Diluted	66,931,819	3,214,074	29,243,883	2,709,309

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders Deficit (Unaudited) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Balance, shares at Apr. 30, 2023		4,839,616	1,803,042
Balance, amount at Apr. 30, 2023	$ (1,919,650)	$ 483	$ 181	$ 14,905,851	$ (16,527,130)	$ (299,035)
Common stock issued for debt conversion, shares			569,681
Common stock issued for debt conversion, amount	14,686	0	$ 57	14,629	0	0
Common stock issued for cash, shares			200,000
Common stock issued for cash, amount	10,000	$ 0	$ 20	9,980	0	0
Common stock issued for preferred B share conversion, shares		(7,208)	72,081
Common stock issued for preferred B share conversion, amount	(8)	$ 0	$ 7	(15)	0	0
Common stock issued for D shares conversion, shares		(3)	115,955
Common stock issued for D shares conversion, amount	12		$ 12	0	0	0
Derivative at conversion	19,354	$ 0	0	19,354	0	0
Dividends on Series D preferred	0	0	0	7,356	(7,356)	0
Net loss	(136,529)	$ 0	$ 0	0	(127,474)	(9,055)
Balance, shares at Jul. 31, 2023		4,832,405	2,760,759
Balance, amount at Jul. 31, 2023	(2,012,135)	$ 483	$ 277	14,957,155	(16,661,960)	(308,090)
Balance, shares at Apr. 30, 2023		4,839,616	1,803,042
Balance, amount at Apr. 30, 2023	$ (1,919,650)	$ 483	$ 181	14,905,851	(16,527,130)	(299,035)
Common stock issued for debt conversion, shares	1,113,579
Common stock issued for debt conversion, amount	$ 23,016
Common stock issued for cash, shares	200,000
Common stock issued for cash, amount	$ 10,000
Balance, shares at Oct. 31, 2023		4,875,655	3,769,657
Balance, amount at Oct. 31, 2023	(2,145,964)	$ 486	$ 378	15,009,693	(16,849,078)	(307,445)
Balance, shares at Jul. 31, 2023		4,832,405	2,760,759
Balance, amount at Jul. 31, 2023	(2,012,135)	$ 483	$ 277	14,957,155	(16,661,960)	(308,090)
Common stock issued for debt conversion, shares			543,898
Common stock issued for debt conversion, amount	8,329	0	$ 54	8,275	0	0
Derivative at conversion	21,819	0	0	21,819	0	0
Net loss	(179,117)	$ 0	$ 0	0	(179,762)	645
Common stock issued for preferred B shares conversion, shares		(41,750)	465,000
Common stock issued for preferred B shares conversion, amount	0	$ (4)	$ 47	(45)	0	0
Series B shares issued for service, shares		85,000
Series B shares issued for service, amount	15,140	$ 7	0	15,133	0	0
Dividend on series D shares	0	$ 0	$ 0	7,356	(7,356)	0
Balance, shares at Oct. 31, 2023		4,875,655	3,769,657
Balance, amount at Oct. 31, 2023	(2,145,964)	$ 486	$ 378	15,009,693	(16,849,078)	(307,445)
Balance, shares at Apr. 30, 2024		4,396,363	9,729,878
Balance, amount at Apr. 30, 2024	(2,362,362)	$ 439	$ 974	15,067,580	(17,116,309)	(315,046)
Dividends on Series D preferred	0	0	0	7,356	(7,356)	0
Net loss	(467,409)	$ 0	$ 0	0	(461,239)	(6,170)
Common stock issued for B preferred conversion, shares		(1,068,686)	10,686,860
Common stock issued for B preferred conversion, amount	0	$ (107)	$ 1,069	(962)	0	0
Common stock issued for D preferred conversion, shares		(7)	431,181
Common stock issued for D preferred conversion, amount	0	$ 0	$ 43	(43)		0
Common stock issued for accrued expense - RP, shares			10,000,000
Common stock issued for accrued expense - RP, amount	695,000	0	$ 1,000	694,000	0	0
Common stock issued for services, shares			100,000
Common stock issued for services, amount	10,000	$ 0	$ 10	9,990	0	0
Balance, shares at Jul. 31, 2024		3,327,664	30,947,919
Balance, amount at Jul. 31, 2024	(2,124,771)	$ 332	$ 3,096	15,777,921	(17,584,904)	(321,216)
Balance, shares at Apr. 30, 2024		4,396,363	9,729,878
Balance, amount at Apr. 30, 2024	(2,362,362)	$ 439	$ 974	15,067,580	(17,116,309)	(315,046)
Balance, shares at Oct. 31, 2024		3,598,969	30,947,919
Balance, amount at Oct. 31, 2024	(1,334,379)	$ 359	$ 3,096	16,181,447	(17,193,733)	(325,548)
Balance, shares at Jul. 31, 2024		3,327,664	30,947,919
Balance, amount at Jul. 31, 2024	(2,124,771)	$ 332	$ 3,096	15,777,921	(17,584,904)	(321,216)
Dividends on Series D preferred	0	0	0	7,356	(7,356)	0
Net loss	394,195	$ 0	0	0	398,527	(4,332)
Series B shares issued for accrued expenses, shares		191,314
Series B shares issued for accrued expenses, amount	789,332	$ 19	0	789,313	0	0
Series B shares issued for accrued expenses-RP, shares		79,991
Series B shares issued for accrued expenses-RP, amount	329,930	$ 8	0	329,922	0	0
Settlement on debt	(723,065)	$ 0	$ 0	(723,065)	0	0
Balance, shares at Oct. 31, 2024		3,598,969	30,947,919
Balance, amount at Oct. 31, 2024	$ (1,334,379)	$ 359	$ 3,096	$ 16,181,447	$ (17,193,733)	$ (325,548)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net loss	$ (73,214)	$ (315,646)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock issued for service	10,000	0
Preferred shares issued for service	0	15,140
(Gain) loss on derivative liability	(7,457)	16,756
Loss on notes	10,000	0
Gain on debt extinguishment	(428,065)	0
Change in operating assets and liabilities:
(Increase) decrease in accounts receivable	0	(31,224)
(Increase) decrease in inventory	0	26,903
Increase (decrease) in accounts payable and accrued expenses	382,953	109,070
Customer deposits	0	10,000
Increase in payables - related parties	65,180	145,099
Net cash provided by (used in) operating activities	(40,603)	(23,902)
Cash flows from financing activities
Proceeds from notes payable- related party	933	1,400
Proceeds from notes payable	40,000	0
Repayment of notes payable	(273)	(5,500)
Proceeds from convertible notes	0	20,000
Proceeds from common stock for cash	0	10,000
Net cash provided by financing activities	40,660	25,900
Net increase (decrease) in cash	57	1,998
Cash at beginning of period	171	804
Cash at end of period	228	2,802
Supplement Disclosures
Interest Paid		0
Income tax Paid		0
Noncash financing and investing activities
Retirement of derivative at debt conversion	0	41,173
Interest accrued on preferred shares	14,712	14,712
Common stock issued for convertible debt	0	21,809
Common stock issued for conversion of Series A preferred	400,000	0
Series B preferred issued for notes payable and accrued interest	0	0
Series B preferred issued for accrued expense	789,332	0
Series B preferred issued for accrued expense - relate parties	$ 331,992	$ 0

BASIS OF PRESENTATION AND ORGAN

BASIS OF PRESENTATION AND ORGANIZATION	6 Months Ended
	Oct. 31, 2024
BASIS OF PRESENTATION AND ORGANIZATION
BASIS OF PRESENTATION AND ORGANIZATION	NOTE – 1: BASIS OF PRESENTATION AND ORGANIZATION Defense Technologies International Corp. (the "Company ") was incorporated in the State of Delaware on May 27, 1998. Effective June 15, 2016, the Company changed its name to Defense Technologies International Corp. from Canyon Gold Corp. to more fully represent the Company's expansion goals into the advanced technology sector. On October 19, 2016, the Company entered into a Definitive Agreement with Controlled Capture Systems, LLC (“CCS”), representing the inventor of the technology and assets previously acquired by DTC, that included a new exclusive Patent License Agreement and Independent Contractor agreement. Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements. The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties as defined in the Definitive Agreement. On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and its subsidiary. The value of the stock will be a discount to the market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive (3) Invoices for parts and materials will be billed separate of the license fees noted above. Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and security protection products previously acquired by the Company. The Company currently owns 76.28% of PSSI with 23.72% acquired by several individuals and entities. The Company’s unique technology works precisely to specifications as required by our technology and as confirmed in the market. All sales and marketing activities will be executed through PSSI. On June 28, 2022 the Company’s common shares were reversed with each shareholder receiving one share of common stock for each 500 shares held before the reverse split. The number of shares throughout the disclosure have been retrospectively adjusted to represent the number of shares after the reverse split. Basis of Presentation These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The Company’s fiscal year end is April 30. The interim condensed consolidated financial statements have been prepared without audit in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q. They do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended April 30, 2024 included in its Annual Report on Form 10-K filed with the SEC. The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s consolidated financial position as of October 31, 2024, the consolidated results of its operations and its consolidated cash flows for the six months ended October 31, 2024 and 2023. The results of operations for any interim period are not necessarily indicative of the results expected for the full fiscal year. Consolidation and Non-Controlling Interest These consolidated financial statements include the accounts of the Company, and its majority-owned subsidiary, PSSI, from its formation on January 12, 2017 to date. All inter-company transactions and balances have been eliminated. Inventory Inventories are stated at the lower of cost using the first-in, first-out (FIFO) cost method of accounting. Inventories as of October 31, 2024 consist of parts used in assembly of the units being sold plus work in progress and finished goods. As of October 31, 2024 and April 30, 2024 the value of the inventory was $7,599. Equipment Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Impairment of Long-Lived Assets We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell. Net Income (Loss) per Common Share Basic net income or loss per common share is calculated by dividing the Company’s net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per common share is calculated by dividing the Company’s net income or loss by sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding stock options and warrants, using the treasury stock method and the average market price per share during the period, and conversion of convertible debt, using the if converted method. As of October 31, 2024, the Company had potential shares issuable under convertible preferred shares and convertible debt for a total of 35,983,900. Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2020-06 Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contract’s in an Entity’s own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods has been amended for small businesses to beginning after December 15, 2023 as early adoption was permitted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company evaluated there is no impact this new guidance will have on its financial statements.

GOING CONCERN

GOING CONCERN	6 Months Ended
	Oct. 31, 2024
GOING CONCERN
GOING CONCERN	NOTE – 2: GOING CONCERN These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern. Through October 31, 2024, the Company had no revenues, has accumulated deficit of $17,193,733 and a working capital deficit of $1,334,379 and expects to incur further losses in the development of its business. The Company has not yet established an ongoing source of revenue sufficient to cover operating costs, which raises substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty. Management plans to continue to provide for the Company's capital needs during the year ending April 30, 2025 by issuing debt and equity securities and by the continued support of its related parties. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

INVESTMENTS

INVESTMENTS	6 Months Ended
	Oct. 31, 2024
INVESTMENTS
INVESTMENTS	NOTE – 3: INVESTMENTS Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company for 17,500 shares of PSSI valued at $378,600 for 76.28% of PSSI. The balance of PSSI was acquired by four individuals and entities. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI. The investment was impaired as of April 30, 2019.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Oct. 31, 2024
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE – 4: RELATED PARTY TRANSACTIONS Management and administrative services are currently compensated as per a Service Agreement between the Company and its Chief Executive Officer and Director executed on April 25, 2016 and a Service Agreement with the subsidiary PSSI executed on January 12, 2017, a Service Agreement between the Company and a Director executed on May 20, 2016, and an Administration Agreement with a related party executed on March 15, 2011 and renewed on May 1, 2017 and renewed in August 21, 2020 plus the assumption of a Service Agreement with the subsidiary PSSI assumed on January 12, 2017 and renewed on August 21, 2020, whereby the fee is based on services provided and invoiced by the related parties on a monthly basis and the fees are paid in cash when possible or with common stock. The Company also, from time to time, has some of its expenses paid by related parties with the intent to repay. These types of transactions, when incurred, result in payables to related parties in the Company’s consolidated financial statements as a necessary part of funding the Company’s operations. On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of October 31, 2024, the outstanding balance on the loan agreement was $150,080 plus accrued interest. During the six months ending October 31, 2023, the Company issued 85,000 series B preferred shares to a related party with a value of $15,140. During the six months ending October 31, 2024 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares. During the six months ending October 31, 2024 the Company issued 10,000,000 shares with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000. During the six months ending October 31, 2024 the Company issued 79,991 shares of series B preferred with a value of $329,930 to 2 related parties for accrued liabilities. The transaction resulted in a gain on debt settlement which was recorded as paid in capital. As of October 31, 2024 and April 30, 2024, the Company had payable balances due to related parties totaling $526,958 and $1,191,708, respectively.

NOTES PAYABLE

NOTES PAYABLE	6 Months Ended
	Oct. 31, 2024
NOTES PAYABLE
NOTES PAYABLE	NOTE – 5: NOTES PAYABLE On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $25,000. The funds were designated for use in a marketing agreement with the Edward Fitzgerald Group for raising funds for PSSI. The note was to be repaid from investment funds generated by the Fitzgerald group plus 15% of the funds generated are paid to the investor. On July 18, 2018, the Company entered into a promissory note of $114,226.26 with interest rate of 8% per annum with Haynie & Company the Company’s former auditors. Under the terms of the agreement commencing August 15, 2018 the Company is to pay Haynie $5,000 per month. In addition, the Company shall pay the noteholder 20% of any funding event of private or public equity. On July 11, 2022, the Company negotiated a settlement of $37,500 with an initial payment of $30,000 and the balance due of $7,500 thirty days after the initial payment. As of October 31, 2024 $7,500 had not been paid leaving the balance due on the note of $20,042. On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of October 31, 2024, the outstanding balance on the loan agreement was $150,680 plus accrued interest. On July 11, 2024 the Company issued a promissory note for $50,000, The note matures in one year from issuance and bears interest at 10% per annum. The note has an initial discount of $10,000 and is not convertible. As of October 31, 2024 and April 30, 2024 the outstanding balances of notes payable was $220,772 and $170,062, respectively.

CONVERTIBLE DEBT

CONVERTIBLE DEBT	6 Months Ended
	Oct. 31, 2024
CONVERTIBLE DEBT
CONVERTIBLE DEBT	NOTE – 6: CONVERTIBLE DEBT On March 10, 2016, the Company entered into a convertible promissory note for $17,000 with ACM Services GmbH, which bears interest at an annual rate of 6% and is convertible into shares of the Company’s common stock at $0.05 per share. The Company recorded a debt discount and a beneficial conversion feature of $17,000 at the inception of the note. As of October 31, 2024 the balance of the notes was $7,000 plus interest. On August 3, 2016, the Company entered into a convertible promissory note with an institutional investor for $25,000, which bears interest at an annual rate of 12% and matures on February 4, 2017. The note holder has the right, after a period of 180 days of the note, to convert the note and accrued interest into shares of the common stock of the Company at a discounted price per share equal to 50% to 65% of the market price of the Company’s common stock, depending upon the stock’s liquidity as determined by the note holder’s broker. On March 20, 2017, the lender converted $12,500 principal into 1,000,000 shares of the Company’s common stock. As of October 31, 2024 the note has a balance of $12,500 plus interest and is currently in default. On October 4, 2018, the Company entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes issued by the Company prior to October 31, 2018. Under the terms of the agreement the Company agreed to accept a six percent interest to be calculated on all the notes since their inception. The agreement resulted in a new note for $330,626 which included the additional interest and retired the original notes. As of October 31, 2024, the outstanding balance was $259,585 plus accrued interest. On March 10, 2022, the Company issued 657,895 shares of series A preferred with a value of $ 25,000 for payment against the convertible note. As of October 31, 2024, and April 30, 2024, the outstanding balance of the note were $259,585 plus interest. During the six months ended October 31, 2023 the Company issued 1,113,579 shares of common stock with a value of $23,016 for the conversion of debt. During the six months ending October 31, 2024 the Company issued 10,000,000 with a value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000. As of October 31, 2024, and April 30, 2024, the convertible debt outstanding, net of discount, was $279,085.

FAIR VALUE MEASUREMENTS AND DER

FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES	6 Months Ended
	Oct. 31, 2024
FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES
FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES	NOTE – 7: FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES As defined in (Financial Accounting Standards Board ASC 820), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. As of October 31, 2024, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration of these instruments. The following table represents the change in the fair value of the derivative liabilities during the six months ended October 31, 2024: Level 1 Level 2 Level 3 Balance at April 30, 2024 $ - $ - $ 37,211 Change in fair value of derivative liability - - (7,457 ) Balance at October 31, 2024 $ - $ - $ 29,754 The estimated fair value of the derivative liabilities at October 31, 2024 was calculated using the Binomial Lattice pricing model with the following assumptions: Risk-free interest rate 5.00 % Expected life in years 0.10 Dividend yield 0 % Expected volatility 251.00 %

EQUITY

EQUITY	6 Months Ended
	Oct. 31, 2024
EQUITY
EQUITY	NOTE – 8: EQUITY Common Stock On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to 600,000,000 with a par value of $0.0001 and the total number of preferred shares at 20,000,000, par value $0.0001. During the six months ended October 31, 2023, the Company issued 200,000 shares of common stock with a value of $10,000 for cash. During the six months ending October 31, 2023, the Company issued 537,081 shares of common stock for the conversion of 53,708 shares of preferred stock. During the six months ended October 31, 2023, the Company issued 1,113,579 shares of common stock with a value of $23,016 for the conversion of debt. During the six months ending October 31, 2024 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares. During the six months ending October 31, 2024 the Company issued 100,000 shares of common stock with a value of $10,000 for the payment of consulting fees. During the six months ending October 31, 2024 the Company issued 431,181 shares of common stock for the conversion of 7 shares of series D preferred shares. During the six months ending October 31, 2024 the Company issued 10,000,000 shares with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000. Preferred Stock The Company has 20,000,000 shares of $0.0001 par value preferred stock authorized and has designated a Series A preferred stock, a Series B preferred stock, a series C preferred stock and a series D preferred stock. The Company has authorized 5,000,000 series A and B shares each plus 1,500,000 each of series C and D preferred shares Each share of the Series A preferred stock is convertible into ten common shares and carries voting rights on the basis of 100 votes per share. Each share of the Series B preferred stock is convertible into ten common shares and carries no voting rights. Each of the Series C preferred shares are non-voting and are convertible to common stock as a “Blank Check” designation with terms and conditions as set by the board of directors. Each of the series D preferred shares are non-voting and may be converted into common shares as a Blank Check” designation with the terms and conditions as set forth by the board of directors On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to 600,000,000 with a par value of $0.0001 and the total number of preferred shares at 20,000,000, par value $0.0001. During the six months ending October 31, 2023, the Company issued 537,081 shares of common stock for the conversion of 53,708 shares of preferred stock. During the six months ending October 31, 2024 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares. During the six months ending October 31, 2024 the Company issued 191,314 shares of series B preferred shares to settle $789,332 for accrued payables. The result of this issuance was a gain on debt of approximately $723,065. During the six months ending October 31, 2024 the Company issued 79,991 shares of series B for settling $329,930 of accrued payables due to related parties. As of October 31, 2024 the Company has 3,598,969 shares of preferred stock consisting of; 2,535,135 Series A shares, 1,063,255 Series B shares and 579 Series D preferred share issued and outstanding. The conversion price for the 579 series D shares issued is $0.50 or 80% of the lowest trading price 20 days prior to conversion,

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Oct. 31, 2024
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE – 9: COMMITMENTS AND CONTINGENCIES The Company has the following material commitments as of October 31, 2024: a) Administration Agreement with EMAC Handel’s AG, renewed effective May 1, 2017 for a period of three years and amended May 1, 2021. Monthly fee for administration services of $7,500, office rent of $250 and office supplies of $125. Extraordinary expenses are invoiced by EMAC on a quarterly basis. The fee may be paid in cash and or with common stock. b) Service Agreement signed April 25, 2016 with Merrill W. Moses, President, Director and CEO, for services of $7,500 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company. The fees may be paid in cash and or with common stock. c) Administration and Management Agreement of PSSI signed January 12, 2017 with EMAC Handel Investments AG, for general fees of $7,500 per month, office rent of $250 and telephone of $125 beginning January 2017 and amended May 1, 2021, the issuance of 2,000 common shares of PSSI and a 12% royalty calculated on defines sales revenues payable within 10 days after the monthly sales. d) Service Agreement of PSSI signed January 12, 2017 with Merrill W. Moses, President, Director and CEO, for services of $2,500 per month beginning February 2017 and the issuance of 333 common shares of PSSI. e) Business Development and Consulting Agreement of PSSI signed January 15, 2017 with WSMG Advisors, Inc., for finder’s fees of 10% of funding raised for PSSI and the issuance of 1,000 common shares of PSSI. On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows. · Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter. · All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive. · Invoices for parts and materials will be billed separate of the license fees noted above.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Oct. 31, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE – 0: SUBSEQUENT EVENTS The Company has evaluated subsequent events to determine events occurring after October 31, 2024 through the filing of this report that would have a material impact on the Company’s financial results or require disclosure other than those noted above.

BASIS OF PRESENTATION AND ORG_2

BASIS OF PRESENTATION AND ORGANIZATION (Policies)	6 Months Ended
	Oct. 31, 2024
BASIS OF PRESENTATION AND ORGANIZATION
Basis of Presentation	These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The Company’s fiscal year end is April 30. The interim condensed consolidated financial statements have been prepared without audit in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q. They do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended April 30, 2024 included in its Annual Report on Form 10-K filed with the SEC. The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s consolidated financial position as of October 31, 2024, the consolidated results of its operations and its consolidated cash flows for the six months ended October 31, 2024 and 2023. The results of operations for any interim period are not necessarily indicative of the results expected for the full fiscal year.
Consolidation and Non-Controlling Interest	These consolidated financial statements include the accounts of the Company, and its majority-owned subsidiary, PSSI, from its formation on January 12, 2017 to date. All inter-company transactions and balances have been eliminated.
Inventory	Inventories are stated at the lower of cost using the first-in, first-out (FIFO) cost method of accounting. Inventories as of October 31, 2024 consist of parts used in assembly of the units being sold plus work in progress and finished goods. As of October 31, 2024 and April 30, 2024 the value of the inventory was $7,599.
Equipment	Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Impairment of Long-lived Assets	We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.
Net Income (Loss) Per Common Share	Basic net income or loss per common share is calculated by dividing the Company’s net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per common share is calculated by dividing the Company’s net income or loss by sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding stock options and warrants, using the treasury stock method and the average market price per share during the period, and conversion of convertible debt, using the if converted method. As of October 31, 2024, the Company had potential shares issuable under convertible preferred shares and convertible debt for a total of 35,983,900.
Recent Accounting Pronouncements	In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2020-06 Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contract’s in an Entity’s own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods has been amended for small businesses to beginning after December 15, 2023 as early adoption was permitted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company evaluated there is no impact this new guidance will have on its financial statements.

FAIR VALUE MEASUREMENTS AND D_2

FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES (Tables)	6 Months Ended
	Oct. 31, 2024
FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES
Schedule of fair value derivative liabilities	Level 1 Level 2 Level 3 Balance at April 30, 2024 $ - $ - $ 37,211 Change in fair value of derivative liability - - (7,457 ) Balance at October 31, 2024 $ - $ - $ 29,754
Schedule of assumptions for estimation of fair value of derivative liabilities	Risk-free interest rate 5.00 % Expected life in years 0.10 Dividend yield 0 % Expected volatility 251.00 %

BASIS OF PRESENTATION AND ORG_3

BASIS OF PRESENTATION AND ORGANIZATION (Details narrative) - USD ($)	1 Months Ended		6 Months Ended
	May 30, 2018	Oct. 19, 2016	Oct. 31, 2024	Apr. 30, 2024
BASIS OF PRESENTATION AND ORGANIZATION
Inventory			$ 7,599	$ 7,599
Issuable shares under convertible preferred shares and convertible debt			35,983,900
Reverse stock split			common shares were reversed with each shareholder receiving one share of common stock for each 500 shares
Initial licensing fee payment		$ 25,000
Amendment to license agreement summary	amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and its subsidiary. The value of the stock will be a discount to the market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive (3) Invoices for parts and materials will be billed separate of the license fees
Acquisition percentage description			The Company currently owns 76.28% of PSSI with 23.72% acquired by several individuals and entities

GOING CONCERN (Details narrativ

GOING CONCERN (Details narrative) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
GOING CONCERN
Accumulated deficit	$ (17,193,733)	$ (17,116,309)
Working capital deficit	$ (1,334,379)

INVESTMENTS (Details Narrative)

INVESTMENTS (Details Narrative)	6 Months Ended
	Oct. 31, 2024
License Agreement [Member]
Equity method investment and ownership increase	The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company for 17,500 shares of PSSI valued at $378,600 for 76.28% of PSSI

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		3 Months Ended	6 Months Ended
	May 02, 2022	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024
Conversion of shares of preferred stock				53,708
Conversion of Stock, Shares Issued				537,081
Note payable- related party			$ 150,080
Short term loans	$ 100,000
Interest rate	6%
Accounts Payable, Related Parties, Current			$ 526,958		$ 1,191,708
Stock Issued During Period, Shares				200,000
Stock Issued During Period, Value		$ 10,000		$ 10,000
Series B Preferred Shares [Member]
Conversion of shares of preferred stock			1,068,686
Conversion of Stock, Shares Issued			10,686,860
Stock Issued During Period, Shares			79,991	85,000
Stock Issued During Period, Value			$ 329,930	$ 15,140
Related Party Debt [Member]
Stock Issued During Period, Shares			10,000,000
Loss on conversion of notes			$ 295,000
Stock Issued During Period, Value			$ 695,000

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)			1 Months Ended
	Jul. 11, 2024	Jul. 11, 2022	Jul. 18, 2018	Oct. 31, 2024	Apr. 30, 2024	May 01, 2022	Mar. 05, 2018
Settlement amount		$ 37,500
Settlement amount, balance due		7,500
Note payable to related party per month			$ 5,000
Initial discount promissory note	$ 10,000
Initial payment promissory note		$ 30,000
EMAC Handels AG [Member]
Short term loans						$ 100,000
Interest rate						6%
Note payable- related party				$ 150,680
Notes Payable [Member]
Promissory note, amount	$ 50,000		$ 114,226
Interest rate	10%		8%
Balance due on notes			$ 20,042
Notes payable				$ 220,772	$ 170,062		$ 25,000

CONVERTIBLE DEBT (Details Narra

CONVERTIBLE DEBT (Details Narrative) - USD ($)				3 Months Ended		6 Months Ended
	May 02, 2022	Mar. 10, 2022	Aug. 03, 2016	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024	Oct. 04, 2018	Mar. 10, 2016
Convertible notes payable, net of discount						$ 279,085		$ 279,085
Stock issued during period, shares, conversion of convertible securities							1,113,579
Common stock issued for debt conversion, value				$ 8,329	$ 14,686		$ 23,016
Interest rate	6%
Stock Issued During Period, Shares							200,000
Stock Issued During Period, Value					$ 10,000		$ 10,000
Convertible Note Payable 1 [Member] | On March 10, 2016 [Member]
Convertible notes payable, net of discount						$ 7,000				$ 17,000
Convertible promissory note										$ 17,000
Common stock shares convertible, price per share						$ 0.05
Interest rate						6%
Convertible Note Payable 5 [Member] | On October 4, 2018 [Member]
Convertible notes payable, net of discount									$ 330,626
Convertible Note Payable 2 [Member] | On August 3, 2016 [Member]
Convertible notes payable, net of discount						$ 12,500
Convertible promissory note			$ 25,000
Debt instrument maturity date			Feb. 04, 2017
Description of right of note holder			note holder has the right, after a period of 180 days of the note, to convert the note and accrued interest into shares of the common stock of the Company at a discounted price per share equal to 50% to 65% of the market price of the Company’s common stock
Stock issued during period, shares, conversion of convertible securities						1,000,000
Common stock issued for debt conversion, value						$ 12,500
Interest rate						12%
Convertible Note Payable 3 [Member] | On February 16, 2018 [Member]
Interest rate						6%
Related Party Debt [Member]
Stock Issued During Period, Shares						10,000,000
Stock Issued During Period, Value						$ 695,000
Loss on conversion of notes						295,000
Series A Preferred Stock [Member]
Share issued during period		657,895
Share issued during period, value		$ 25,000
Outstanding balance of notes						$ 259,585		$ 259,585

FAIR VALUE MEASUREMENTS AND D_3

FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES (Details) - USD ($)	6 Months Ended
	Oct. 31, 2024	Apr. 30, 2024
Fair Value, Inputs, Level 3 [Member]
Derivative liability	$ 29,754	$ 37,211
Change in fair value of derivative liability	(7,457)
Fair Value, Inputs, Level 2 [Member]
Derivative liability	0	0
Change in fair value of derivative liability	0
Fair Value, Inputs, Level 1 [Member]
Derivative liability	0	$ 0
Change in fair value of derivative liability	$ 0

FAIR VALUE MEASUREMENTS AND D_4

FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES (Details 1) - Fair Value of Derivative Liabilities [Member]	6 Months Ended
	Oct. 31, 2024
Risk-free interest rate	5%
Expected life in years	1 month 6 days
Dividend yield	0%
Expected volatility	251%

EQUITY (Details Narrative)

EQUITY (Details Narrative) - USD ($)	3 Months Ended			6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024	Apr. 26, 2022
Common Stock, Par or Stated Value Per Share	$ 0.0001			$ 0.0001		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000			20,000,000			20,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.0001			$ 0.0001			$ 0.0001
Common stock issued for convertible debt, shares					1,113,579
Common stock issued for debt conversion, value		$ 8,329	$ 14,686		$ 23,016
Conversion of shares of preferred stock					53,708
Common Stock, Shares Authorized							600,000,000
Conversion of Stock, Shares Issued					537,081
Stock Issued During Period, Shares					200,000
Stock Issued During Period, Value			$ 10,000		$ 10,000
Gain in debt settlement	$ 723,065	0		$ 723,065	0
Preferred Stock, Shares Issued	3,598,969			3,598,969
Loss on notes	$ 0	$ 0		$ (5,000)	$ 0
Series B shares issued for accrued expenses, amount	789,332
Series B shares issued for accrued expenses-RP, amount	$ 329,930
Consulting Fees [Member]
Stock Issued During Period, Shares				100,000
Stock Issued During Period, Value				$ 10,000
Related Party Debt [Member]
Stock Issued During Period, Shares				10,000,000
Stock Issued During Period, Value				$ 695,000
Loss on notes				$ 295,000
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized	20,000,000			20,000,000		20,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.0001			$ 0.0001		$ 0.0001
Voting rights	100			100
Preferred Stock, Shares Issued	2,535,135			2,535,135		2,535,135
Preferred Stock, Shares Outstanding	2,535,135			2,535,135		2,535,135
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized	5,000,000			5,000,000
Conversion of shares of preferred stock				1,068,686
Conversion of Stock, Shares Issued				10,686,860
Voting rights	100			100
Gain in debt settlement				$ 723,065
Preferred Stock, Shares Issued	1,063,255			1,063,255		1,860,636
Preferred Stock, Shares Outstanding	1,063,255			1,063,255		1,860,636
Series B shares issued for accrued expenses, shares				191,314
Series B shares issued for accrued expenses, amount				$ 789,332
Series B shares issued for accrued expenses-RP, shares				79,991
Series B shares issued for accrued expenses-RP, amount				$ 329,930
Series D Preferred Stock [Member]
Preferred Stock, Shares Authorized	1,500,000			1,500,000
Preferred Stock, Shares Issued	579			579		600
Preferred Stock, Shares Outstanding	579			579		600
Series B Preferred Shares [Member]
Conversion of shares of preferred stock				1,068,686
Conversion of Stock, Shares Issued				10,686,860
Stock Issued During Period, Shares				79,991	85,000
Stock Issued During Period, Value				$ 329,930	$ 15,140
Series D Preferred Shares [Member]
Conversion of shares of preferred stock				7
Stock Issued During Period, Shares				431,181
Series C Preferred Stock [Member]
Preferred Stock, Shares Authorized	1,500,000			1,500,000
Preferred Stocks [Member]
Common Stock, Par or Stated Value Per Share							$ 0.0001
Preferred Stock, Shares Authorized							20,000,000
Preferred Stock, Par or Stated Value Per Share							$ 0.0001
Conversion of shares of preferred stock					53,708
Common Stock, Shares Authorized							600,000,000
Conversion of Stock, Shares Issued					537,081

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	6 Months Ended
	Oct. 31, 2024	May 01, 2021	May 30, 2018
EMAC Handels AG [Member]
Monthly fee for administration services	$ 7,500
Monthly fee for Office Rent	250
Monthly fee for Office Supplies	125
Merrill W Moses [Member]
Monthly fee for administration services	$ 2,500
Issuance of common stock shares	333
Issuance of restricted common shares	233
Monthly Director's fee per Service Agreement	$ 7,500
WSMG Advisors [Member]
Issuance of common stock shares	1,000
Control Capture Systems, LLC [Member]
Represents the minimum royalty payment per quarter	$ 12,500
Royalty percentage			5%
Discounted market percentage			25%
PSSI [Member]
Monthly fee for administration services	7,500
Monthly fee for Office Rent	250
Shares issued		2,000
Royalty percentage		12%
Monthly fee for telephone	$ 125